Journal of Enzyme Inhibition and Medicinal Chemistry 2012-04-01

Synthesis of a novel series of L-isoserine derivatives as aminopeptidase N inhibitors.

Kanghui Yang, Jinghong Fen, Hao Fang, Lei Zhang, Jianzhi Gong, Wenfang Xu

Index: J. Enzyme Inhib. Med. Chem. 27(2) , 302-10, (2012)

Full Text: HTML

Abstract

A series of novel L-isoserine derivatives were synthesised and evaluated for their ability to inhibit aminopeptidase N (APN)/CD13. In our preliminary biological results, some of these compounds possessed a potent inhibitory activity against the APN. Within this series, compound 14b not only showed similar enzyme inhibition (IC₅₀ of 12.2 μM) compared with the positive control bestatin (half maximal inhibitory concentration (IC₅₀) of 7.3 μM), but also had a potent antiproliferative activity against human cancer cell lines cells.

Related Compounds

Structure Name/CAS No. Articles
L-(-)-Serine Structure L-(-)-Serine
CAS:632-13-3
(2S)-3-Amino-2-hydroxypropanoic acid Structure (2S)-3-Amino-2-hydroxypropanoic acid
CAS:632-11-1
Ubenimex Structure Ubenimex
CAS:58970-76-6
Isoserine Structure Isoserine
CAS:565-71-9
Bestatin hydrochloride Structure Bestatin hydrochloride
CAS:65391-42-6